A multicenter comparison of nicorandil a
โ
Jun Sasaki; Yoshihisa Saeki; Kazuya Kawasaki; Morio Umeno; Kenjiro Ikeda; Koichi
๐
Article
๐
1992
๐
Springer US
๐
English
โ 328 KB
The effects of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in 37 patients with ischemic heart disease were examined in a randomized, multicenter study. Nicorandil (n = 20, 10-40 mg/day, b.i.d.) and diltiazem (n = 17, 60-240 mg/day, b.i.d.) were administered for 12